about
The effect of activated protein C on experimental acute necrotizing pancreatitisCorrection: The effect of activated protein C on experimental acute necrotizing pancreatitisMetformin: good or bad for the brain?Peripheral artery disease assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherothrombosis--CAREFUL study: a national, multi-center, cross-sectional observational study.A new combination therapy in severe acute pancreatitis--hyperbaric oxygen plus 3-aminobenzamide: an experimental studyUltrastructural changes in hepatocytes after taurine treatment in CCl4 induced liver injuryThe plasma levels of soluble P-selectin in subjects with prediabetes.Diagnosing options in patient with sarcopeniaAnkle-brachial index, peripheral arterial disease, and diabetic retinopathy.Sarcopenia Is a Condition With Increasing Importance in Medical Oncology.Depression and anxiety disorders among gastroenterologic outpatientsChitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus.Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome.Time course relationships among hypertension, cognition and depression in the elderly.Adipokines and cytokines in non-alcoholic fatty liver disease.Deferoxamine and meropenem combination therapy in experimental acute pancreatitis.The effect of combination therapy of hyperbaric oxygen, meropenem, and selective nitric oxide synthase inhibitor in experimental acute pancreatitis.Plasma adiponectin and insulin resistance in new onset hypertension.Re. Pre- and perioperative factors affecting infection after living donor liver transplantation.Comment on "Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men".Abdominal obesity is associated with a lower ankle-brachial index in women with polycystic ovary syndrome.Adipocytokine levels in chronic pancreatitis.Adiponectin levels in patients undergoing coronary stenting.Comment to "age-related changes in body composition in a sample of Czech women aged 18-89 years: a cross-sectional study".Rosiglitazone for nonalcoholic steatohepatitis.Re: Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.Asymmetric dimethylarginine levels decrease because of insulin infusion: is it an unexpected finding?LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia.Allopurinol in rat chronic pancreatitis: effects on pancreatic stellate cell activation.Maprotiline induced weight gain in depressive disorder: changes in circulating ghrelin and adiponectin levels and insulin sensitivity.Assessment of geriatric predictors of adherence to Zoledronic acid treatment for osteoporosis: a prospective follow-up study.Evaluation of self-administered versus interviewer-administered completion of Edinburgh Claudication Questionnaire.Galantamine improves sleep quality in patients with dementia.Comment on "metabolic syndrome and elevated C-reactive protein levels in elderly patients with newly diagnosed depression".Glycemic control and the risk of microvascular complications in people with diabetes mellitus.Acid-base disturbances may complicate the diagnosis of refeeding syndrome.Oxidative stress, obstructive sleep apnea and cardiovascular disease.Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults.Persistent physical activities in leisure time over decades improve late life CVD markers.Plasma apelin is lower in patients with elevated LDL-cholesterol.
P50
Q24811564-D7733F79-EBA6-4083-8B3E-CC8B27E6C7B3Q24811791-C3049A7F-8777-4297-8A59-9DEF0BF53D30Q34357962-52A18E85-572C-46BF-89E9-7F2B35E03A31Q34552821-896AA861-5D7C-4BD0-9675-4B2A37F6AD20Q35081700-72E53E0C-D921-4892-BA14-8AB5ABE7CD78Q37338030-FE755547-0077-4A09-AF12-6DF7DE69C5CAQ40293267-BAB8DFF9-3D26-48C1-8845-69DFE27D876EQ42424914-DCDB7123-05A0-4934-9D50-4C679E2B4BF3Q42549178-D82DB841-CAF2-458B-8863-FA377A66EDDBQ42558776-3E9D19C4-C318-4E63-8DE4-2C4F0D494825Q42672519-6D6A38F3-C2DC-4C95-8F10-737E73B9F06FQ42853671-73006775-7728-4D4F-913B-6D2733D65DF9Q43711916-CB0D64AA-386F-4C7B-B4B5-3BCCFC38DD49Q44179738-FB680131-8FE6-4306-B479-DD238C5C529AQ44508218-F7499BFD-3F0B-4E09-921E-894A891F7C2FQ44595467-448B577B-BBA1-4D4B-8BA2-7F9281D67ACCQ44715470-927D8697-7050-4B89-85BF-A10760C3012FQ44839458-97E141F0-5451-412A-AD98-6F33E1EDAA6AQ45023186-5C0AB904-21F9-475D-9FB5-66731294D2FFQ45218273-9FAB86B1-4B8E-4182-987C-71DBACAF9700Q45756739-A167B54D-88E1-44C5-A3FF-0EDBB468DFBBQ46038567-FBFFA645-31FB-4EC9-8ABF-EDCB1090D134Q46088379-A6B57DEC-DF57-4D2C-B285-649B49F4E299Q46226803-E1F1D047-E591-4375-A6E0-A91B0B8255E7Q46243304-6085DDA6-9B0C-49F4-A926-15D64533715CQ46300254-1D431A64-94E4-4D57-8066-9362D738FDA6Q46305532-B678F7E5-BD65-428D-B002-736B7E9C6BF3Q46323342-AE6A3E9B-E816-4B4F-A05B-AD47A0450986Q46843173-41969CFA-DA91-48E8-99D1-F63855DEC304Q47271352-A96ACE86-63FE-42CC-A741-F77B2881A56FQ47563434-931730D4-16D8-4685-83DD-B15BF42D5B34Q47852137-61F5045D-6EB7-44DD-A6A3-8FBF8FED7A24Q47987403-33E39E10-58C6-4681-AB67-7D1C3E5735FDQ48100977-DE236B44-40FB-4198-8A21-BD98F27B4BE7Q48176867-5D5495B4-B842-4D30-9A3C-E4D89AA58D57Q48287193-89597EAA-A596-438E-B0F4-FE746C9BC996Q48295140-6F39DC35-DB18-490F-96E2-A9D7EA06DB3BQ49360870-63FB37A4-246F-4EC8-8659-5508CDA02741Q49589789-60B2D062-8679-42B8-A502-B72AB7B17F26Q51467188-52FD951C-A92D-4707-B188-4C55A3B385E7
P50
description
researcher ORCID ID = 0000-0002-0936-2476
@en
name
Ilker Tasci
@ast
Ilker Tasci
@en
Ilker Tasci
@es
Ilker Tasci
@nl
type
label
Ilker Tasci
@ast
Ilker Tasci
@en
Ilker Tasci
@es
Ilker Tasci
@nl
prefLabel
Ilker Tasci
@ast
Ilker Tasci
@en
Ilker Tasci
@es
Ilker Tasci
@nl
P1153
35565314900
P31
P496
0000-0002-0936-2476